Purchase Order 75N92E18P00095

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $5,712.00 on August 18, 2017, with ultimate completion by September 15, 2017. Place of performance is Bethesda, Maryland. The order is priced firm fixed price with no set-aside designation. Specific deliverables or line items are not detailed in the source.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $5,172.00 on August 2, 2017, for completion by September 1, 2017. Place of performance is North Bethesda, Maryland. The order is for firm fixed price commercial items, with no small business set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on July 19, 2018, for $3,038.08, with an ultimate completion date of September 9, 2019. Work is performed in North Bethesda, Maryland. The order is a firm fixed price acquisition for commercial laboratory supplies or reagents supporting genomic research infrastructure. No small business set-aside applies.</p>

<p>The National Human Genome Research Institute issued a purchase order to Medical Neurogenetics, LLC on February 6, 2018, for clinical genetic testing with a ceiling value of $249,481.00. Work is performed in Bethesda, Maryland. The order was completed by November 2, 2023. Pricing is firm fixed price with no small business set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Chesapeake Mission Critical LLC valued at $13,871.00 on August 25, 2017, with a completion date of September 8, 2017. Work is performed in Bethesda, Maryland. The order is priced on a firm-fixed-price basis with no set-aside applied. Specific requirements are not detailed in the source material.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Golden Helix Inc. valued at $6,991.00 on June 22, 2017, for a firm fixed price.</p> <p>Place of performance is Bethesda, Maryland. The order ultimate completion date is August 1, 2018. No set-aside applies to this purchase order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $9,207 on July 28, 2017. Performance is located in North Bethesda, Maryland. The order carries firm fixed pricing with an ultimate completion date of August 27, 2017. No set-aside category applies.</p>